
Bayer AG owns 1 brand in our database. Browse the complete portfolio of Bayer AG subsidiaries and brands across various industries.
Company Type
public
Headquarters
Leverkusen, Germany
Brand Portfolio
1 brands
Stock
XETRA (Frankfurt Stock Exchange): BAYN
Showing Sports brands
1 of 1 total brands
Who owns Bayer?
Bayer AG is publicly traded on the XETRA/Frankfurt Stock Exchange under ticker BAYN with no controlling shareholder. Institutional investors including BlackRock, Vanguard Group, and other large investment management firms collectively hold the majority of outstanding shares. No individual, family, or private equity firm holds a controlling interest. The company operates under German corporate governance with a two-tier board system.
What is Bayer's annual revenue?
Bayer reported Group sales of EUR 45.575 billion for fiscal year 2025, a decrease of 2.2% on a reported basis but an increase of 1.1% on a currency- and portfolio-adjusted basis. EBITDA before special items was EUR 9.669 billion (down 4.5%), and net income was EUR -3.620 billion due to high special charges for litigation. For Q2 2026, Group sales were EUR 10.872 billion (up 2.2% adjusted), and the company confirmed its currency-adjusted outlook for 2026.
What brands does Bayer own?
Bayer owns pharmaceutical brands including Xarelto, Eylea, Nubeqa, and Kerendia; consumer health brands including Aspirin, Aleve, Claritin, Coppertone, and Bepanthen; and agricultural brands including Roundup, DeKalb, Climate FieldView, Preceon Smart Corn System, and Plenexos. The company also owns Bayer 04 Leverkusen football club, which won its first Bundesliga title in the 2023/24 season.
What is the Roundup litigation at Bayer?
The Roundup litigation involves claims alleging that Monsanto's Roundup herbicide causes cancer due to glyphosate exposure, inherited through Bayer's 2018 acquisition of Monsanto. In 2025, Monsanto agreed with leading plaintiff law firms on a proposed nationwide class settlement establishing a long-term claims program funded by declining capped annual payments for up to 21 years. In June 2026, the U.S. Supreme Court ruled 7:2 in the Durnell case that FIFRA preempts state-law failure-to-warn claims, which should result in the dismissal of current warnings-based claims and foreclose future claims.
Who is the CEO of Bayer?
Bill Anderson has served as CEO of Bayer AG since June 2023. He has led a significant turnaround focused on four strategic priorities: rejuvenating the Pharmaceuticals pipeline, executing the Crop Science Five-Year Framework, significantly containing litigation by the end of 2026, and driving efficiency through a new operating model. Under his leadership, Bayer has reduced net financial debt and headcount while advancing its pipeline.
Is Bayer publicly traded?
Yes, Bayer AG is publicly traded on the XETRA/Frankfurt Stock Exchange under the ticker symbol BAYN. The company has been publicly traded since its re-establishment in 1951 and is a component of the DAX 40 index, Germany's premier stock market index. The proposed dividend for FY2025 is EUR 0.11 per share, maintained at a reduced level to prioritize debt reduction.
What is the Monsanto acquisition and why is it controversial?
Bayer acquired Monsanto in 2018 for approximately $63 billion, making it the world's largest seed and agrochemical company. The acquisition has been widely criticized because it brought approximately 100,000+ Roundup (glyphosate) cancer claims, PCB litigation, and a massive debt burden. The litigation has cost Bayer billions in settlements and special charges, and the company's stock price and dividend have been significantly impacted. The acquisition is considered one of the most value-destructive deals in pharmaceutical industry history.
What is Bayer's sustainability strategy?
Bayer's sustainability strategy is aligned with its mission "Health for all, Hunger for none" and includes commitments to achieve Net Zero GHG emissions by 2050 (SBTi-approved), reduce water use per kilogram of crop by 25% by 2030 for smallholder rice farmers, reduce water withdrawals in Pharmaceuticals and Consumer Health by 20% by 2030, transition all Consumer Health products to 100% recycle-ready packaging, and improve access to medicine and self-care globally. The company also invests in regenerative agriculture with a target of 250,000 tons of wheat from regenerative farming.
No competing brands found in the same categories. This could be because Bayer AGoperates in unique market segments or we're still building our competitor database.
Bayer AG maintains a diverse portfolio of 1 brands across multiple industries. This comprehensive brand portfolio demonstrates the company's market presence and strategic business units.
For consumers and researchers interested in corporate ownership structures, understanding which brands are owned by Bayer AGprovides valuable insights into market dynamics, product relationships, and corporate strategy.